Nasdaq podd.

The following insiders have purchased PODD shares in the last 24 months: James Hollingshead ($1,006,825.50), and Prem Singh ($168.92). How much insider buying is happening at Insulet? Insiders have purchased a total of 5,551 PODD shares in the last 24 months for a total of $1,006,994.42 bought.

Nasdaq podd. Things To Know About Nasdaq podd.

Track Insulet Corporation (PODD) Stock Price, Quote, latest community messages, chart, news and other stock related information.Thus, Insulet has an ROCE of 3.5%. Ultimately, that's a low return and it under-performs the Medical Equipment industry average of 8.9%. NasdaqGS:PODD Return on Capital Employed October 11th 2021Insulet (PODD) closed at $312.36 in the latest trading session, marking a +1.45% move from the prior day. This move lagged the S&P 500's daily gain of 1.76%. Elsewhere, the Dow gained 1.17%, while ...In the latest trading session, Insulet (PODD) closed at $305.89, marking a -0.13% move from the previous day. This change lagged the S&P 500's 0.4% gain on the day. Meanwhile, the Dow gained 0.33% ...

Stock. Insulet Corporation Common Stock. Official Company Name: Insulet Corporation. Stock Symbol: PODD. Stock Market: NASDAQ Global Select - NASDAQ.Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its ...

Insulet Corporation (PODD) is a leading medical device company that is dedicated to creating advanced insulin delivery systems for individuals with diabetes. Their flagship product is designed to ...PODD Latest Real Time Trades. Select time range to see more trades: Last 100 Trades. ...

INSULET CORPORATION ( PODD) is a large-cap growth stock in the Medical Equipment & Supplies industry. The rating using this strategy is 77% based on the firm’s underlying fundamentals and the ...Insulet (PODD) closed the most recent trading day at $289.70, moving -0.68% from the previous trading session. This change lagged the S&P 500's 0.02% loss on the day. Elsewhere, the Dow gained 0. ...Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods.View the latest Insulet Corp. (PODD) stock price, news, historical charts, analyst ratings and financial information from WSJ.01-Nov-2023 ... Insulet (Nasdaq:PODD) today announced a series of initiatives to recognize National Diabetes Awareness Month and World Diabetes Day.

PODD Insulet Corp NASDAQ 188.51 -0.41 -0.22% Opening 13:12 11/30 EST OPEN 188.80 PREV CLOSE 188.92 HIGH 190.29 LOW 185.73 VOLUME 276.05K TURNOVER 0 52 …

Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its ...

In the latest trading session, Insulet (PODD) closed at $286.13, marking a -1.23% move from the previous day. This change lagged the S&P 500's 1.1% gain on the day. At the same time, the Dow added ...21-Aug-2023 ... Fintel reports that on August 21, 2023, Citigroup upgraded their outlook for Insulet (NASDAQ:PODD) from Neutral to Buy .Insulet Corporation (PODD) is a leading medical device company that is dedicated to creating advanced insulin delivery systems for individuals with diabetes. Their flagship product is designed to ...-8.46 -1.71% Insulet Corporation Common Stock (PODD) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.November 24, 2023. Insulet Corporation (NASDAQ: PODD) is a company that has recently experienced both positive and negative market performance. While its stock price has plunged by 4.14% in relation to the previous closing price of 174.06, it has seen a 10.72% surge over the last five trading sessions. This volatility raises questions about ...

14-Nov-2023 ... ... nasdaq Closing Bell. 🛎️ As an innovative medical device company, #NasdaqListed $PODD is helping to simplify life for people living with ...“Insulet Corporation (NASDAQ:PODD) is a medical device company focused on the design, development and commercialization of insulin pump systems for people with type 1 diabetes. Diabetes is a ...As of April 24, 2023, the average one-year price target for Insulet is 346.80. The forecasts range from a low of 294.92 to a high of $393.75. The average price target represents an increase of 5. ...The latest price target for . Insulet (NASDAQ: PODD) was reported by Piper Sandler on Friday, November 3, 2023.The analyst firm set a price target for 250.00 expecting PODD to rise to within 12 ...Insulet Corporation (NASDAQ:PODD)’s traded shares stood at 1.48 million during the last session, with the company’s beta value hitting 0.83. At the close of trading, the stock’s price was $140.44, to imply an increase of 1.98% or $2.72 in intraday trading. The PODD share’s 52-week high remains $335.91, putting it -139.18% down since ...

SEC Filings (Institutional Ownership Changes) for Insulet (NASDAQ:PODD) Institutional Buying and Selling by Quarter. This chart shows the instiutional buying and selling at PODD by year and by quarter. Skip Institutional Buying and Selling Chart and Table Data Read Chart Data in Institutional Trading History Table.While the historical EPS growth rate for Insulet is 52.2%, investors should actually focus on the projected growth. The company's EPS is expected to grow 1513% this year, crushing the industry ...

Insulet (NASDAQ:PODD) Might Have The Makings Of A Multi-Bagger Jul 31. Insulet Corporation to Report Q2, 2023 Results on Aug 08, 2023. Jul 06. Insulet …Based on analysts offering 12 month price targets for PODD in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 .The forecasts range from a low of 322.19 to a high of $414.75. The average price target represents an increase of 57.05% from its latest reported closing price of 229.69. See our leaderboard of ...Insulet Corporation (NASDAQ:PODD) shareholders might be concerned after seeing the share price drop 13% in the last month. But that doesn't change the fact that the returns over the last five ...The stock has gained 47.7% compared with the industry’s 15.1% rise. Insulet exited the second quarter of 2021 with better-than-expected revenues. The year-over-year improvement in the top line ...Research Insulet's (Nasdaq:PODD) stock key valuation metrics while comparing it with its industry peers & market side by side. Dashboard Markets Discover Watchlist Portfolios Screener. Insulet Corporation. NasdaqGS:PODD Stock Report. ... What is PODD's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the ...PODD NASDAQ. PODD NASDAQ. PODD NASDAQ. Market closed Market closed. No trades. See on Supercharts. Overview News Ideas . Financials . Technicals Forecast . PODD fundamentals. Overview Statements Statistics Dividends Earnings Revenue More. Insulet Corporation financial statements, including revenue, expenses, profit, and loss.PODD currently has a PEG ratio of 6.08. Another notable valuation metric for ESLOY is its P/B ratio of 2.09. The P/B is a method of comparing a stock's market value to its book value, which is ...74.86. +0.25%. 17.03M. View today's Insulet Corporation stock price and latest PODD news and analysis. Create real-time notifications to follow any changes in the live stock price.

Insulet Corporation (NASDAQ: PODD)’s stock price has gone rise by 5.55 in comparison to its previous close of 155.10, however, the company has experienced a 3.01% increase in its stock price over the last five trading days. Zacks Investment Research reported 2023-11-10 that Insulet (PODD) could produce exceptional returns because of its solid growth attributes. […]

While the historical EPS growth rate for Insulet is 52.2%, investors should actually focus on the projected growth. The company's EPS is expected to grow 1741.4% this year, crushing the industry ...

Mar 17, 2023 · Insulet (PODD) closed the most recent trading day at $309.09, moving -1.05% from the previous trading session. This move was narrower than the S&P 500's daily loss of 1.1%. Elsewhere, the Dow lost ... Insulet Corporation (NASDAQ:PODD) is a prime example of this. The company makes a tubeless pump, called an Omnipod, for people with diabetes. The company makes a tubeless pump, called an Omnipod ...Founded in 2000 (NASDAQ: PODD), Insulet operates with a customer-centric focus to supply high-quality products and expand the use of insulin pump therapy. Omnipod products are now available in 20 ...Oct 30, 2023 · One-month return of Insulet Corporation (NASDAQ:PODD) was -20.57%, and its shares lost 49.35% of their value over the last 52 weeks. Insulet Corporation (NASDAQ:PODD) has a market capitalization ... Nov 20, 2023 · Turning to the calls side of the option chain, the call contract at the $180.00 strike price has a current bid of $34.30. If an investor was to purchase shares of PODD stock at the current price ... Insulet Corporation Common Stock (PODD) Pre-Market Quotes | Nasdaq. Created with Sketch. Market Activity. Funds + ETFs. P/E & PEG Ratios. Data is delayed at least 15 minutes. Nasdaq.com will ... How much is Insulet stock worth today? ( NASDAQ: PODD) Insulet currently has 69,821,118 outstanding shares. With Insulet stock trading at $162.58 per share, the total value of Insulet stock (market capitalization) is $11.35B. Insulet stock was originally listed at a price of $15.96 in May 15, 2007.Insulet (NASDAQ: PODD), headquartered in Acton, Massachusetts, and with offices and manufacturing facilities around the world, is a global company with growing reach. We strive to bring our innovations to all who need them, wherever they are. Oct 17, 2023 · Fintel. Fintel reports that on October 17, 2023, JP Morgan maintained coverage of Insulet (NASDAQ:PODD) with a Overweight recommendation. Analyst Price Forecast Suggests 109.29% Upside As of ... Add symbols now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing stocks, funds and ETFs, and more asset classes. Add/Edit Symbols Edit …Management criteria checks 3/4. Insulet's CEO is Jim Hollingshead, appointed in Jun 2022, has a tenure of 1.42 years. total yearly compensation is $11.18M, comprised of 3.9% salary and 96.1% bonuses, including company stock and options. directly owns 0.018% of the company’s shares, worth $2.41M. The average tenure of the management team and ...

Insulet Corporation (NASDAQ:PODD) trade information. Sporting 3.82% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Monday, 11/13/23 when the PODD stock price touched $169.96 or saw a rise of 2.8%.Nov 24, 2023 · Insulet Co. (NASDAQ:PODD – Free Report) – Stock analysts at Leerink Partnrs raised their Q2 2024 earnings per share (EPS) estimates for Insulet in a report released on Monday, November 20th. Leerink Partnrs analyst M. Kratky now expects that the medical instruments supplier will earn $0.80 per share for the quarter, up from their previous […] Nov 28, 2023 · Read Full Company Summary for PODD here. View Insulet Corporation PODD investment & stock information. Get the latest Insulet Corporation PODD detailed stock quotes, stock data, Real-Time ECN ... Instagram:https://instagram. best algorithmic trading software for beginnersbest day trading stocks under dollar5unusual options flowibm stock price forecast Insulet Corporation (PODD.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Insulet Corporation | Nasdaq: PODD | NasdaqThe price-to-earnings ratio for Insulet Corporation (NASDAQ: PODD) is above average at 92.44x. The 36-month beta value for PODD is also noteworthy at 0.87. There are mixed opinions on the stock, with 15 analysts rating it as a “buy,” 3 rating it as “overweight,” 6 rating it as “hold,” and 0 rating it as “sell.”. monolithic power systems inc.sell ipad locally Founded in 2000 (NASDAQ: PODD), Insulet operates with a customer-centric focus to supply high-quality products and expand the use of insulin pump therapy. Omnipod products are now available in 20 ... nasdaq emini Insulet Corporation (PODD) NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Follow. 2W 10W 9M. 162.58 +22.14 (+15.76%) At close: 04:00PM EDT. 162.75 +0.17 (+0.10%) After hours: 07:53PM EDT. Founded in 2000 (NASDAQ: PODD), Insulet operates with a customer-centric focus to supply high-quality products and expand the use of insulin pump therapy. Omnipod products are now available in 20 ...